Embracing continuous manufacturing in the pharmaceutical industry
Drugmakers have been slow to adopt the production process, which experts say can streamline operations, boost data quality and reduce time to market.
Drugmakers have been slow to adopt the production process, which experts say can streamline operations, boost data quality and reduce time to market.
In recent decades, extensive investigations on the human genome have unveiled numerous genes associated with genetic diseases and consequently led to the emergence of a therapeutic approach called gene therapy.
The forward movement of the biopharma industry is driven by fast-paced advancement in manufacturing technology innovations. As manufacturing technology advances, so does the shift to continuous manufacturing (CM), a process that enables real-time monitoring, improved scalability, and enhanced quality control.